Inspira Technologies (IINN) announced that it has completed the regulatory submission of its FDA-cleared INSPIRA ART100 system to the United Arab Emirates Ministry of Health and Prevention. Final approval is expected within days, marking a decisive step toward commercial entry into the Gulf region. This regulatory milestone follows successful high-level government discussions in the UAE, during which Inspira laid the groundwork for potential nationwide deployment and clinical integration of the ART100 system following the approval by the MOHAP. The achievement further advances Inspira’s global commercialization roadmap.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IINN:
- Inspira Technologies and Bites Forge AI Alliance to Enhance Global Medical Training
- Inspira Technologies announces strategic collaboration with Bites Learning
- Inspira Technologies Strengthens Leadership with Key Appointments
- Inspira Technologies appoints Hershkovitz as VP, Matza to board
- Inspira Technologies Announces Major Milestones and Financial Results for First Half of 2025